About
Back
Leadership Team
Board of Directors
Scientific Advisors
Platform Technologies
Back
Versamune
®
Back
About Versamune
®
Introduction to Immunotherapies
Infectimune™
Back
About Infectimune™
Transformative Vaccines
Partnerships
Publications
Pipeline
Back
Overview
Oncology
Back
PDS0101
PDS0102
PDS0103
PDS0104
Infectious Disease
Back
PDS0201
PDS0202
PDS0203
Clinical Trials
Back
VERSATILE-002
Expanded Access
Investors and Media
Back
News Center
Back
Press Releases
Back
News 2022
News 2021
News 2020
News 2019
Events
Media Resources
Investor Resources
Back
Corporate Presentations
FAQs
Investor Email Alerts
Stock Info
Back
Stock Quote and Chart
Historical Price Lookup
Analyst Coverage
SEC Filings
Corporate Governance
Back
Governance Documents
Committee Composition
CEO Message
Contact
Back
Media
Investors
Business Development and Licensing
Sign Up
Search
Contact
Business Development and Licensing Contact
Deanne Randolph
Phone (908) 517-3613
Receive Email Alerts
Join our mailing list to receive the latest news and updates from our team.
Sign up
